{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:05:34Z","timestamp":1761843934691},"reference-count":45,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"crossref","award":["C28248\/A9058"],"award-info":[{"award-number":["C28248\/A9058"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1016\/j.bcp.2010.01.031","type":"journal-article","created":{"date-parts":[[2010,2,5]],"date-time":"2010-02-05T09:18:31Z","timestamp":1265361511000},"page":"1581-1588","source":"Crossref","is-referenced-by-count":19,"title":["A simple yeast-based system for analyzing inhibitor resistance in the human cancer drug targets Hsp90\u03b1\/\u03b2"],"prefix":"10.1016","volume":"79","author":[{"given":"Stefan H.","family":"Millson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chrisostomos","family":"Prodromou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter W.","family":"Piper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2010.01.031_bib1","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.molcel.2006.12.008","article-title":"An acetylation site in the middle domain of Hsp90 regulates chaperone function","volume":"25","author":"Scroggins","year":"2007","journal-title":"Mol Cell"},{"key":"10.1016\/j.bcp.2010.01.031_bib2","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1042\/BJ20071640","article-title":"The Hsp90 molecular chaperone: an open and shut case for treatment","volume":"410","author":"Pearl","year":"2008","journal-title":"Biochem J"},{"key":"10.1016\/j.bcp.2010.01.031_bib3","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s12038-007-0051-y","article-title":"Heat shock protein 90: the cancer chaperone","volume":"32","author":"Neckers","year":"2007","journal-title":"J Biosci"},{"key":"10.1016\/j.bcp.2010.01.031_bib4","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nature01913","article-title":"A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors","volume":"425","author":"Kamal","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2010.01.031_bib5","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1196\/annals.1391.012","article-title":"Drugging the cancer chaperone HSP90: combinatorial therapeutic exploitation of oncogene addiction and tumor stress","volume":"1113","author":"Workman","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.bcp.2010.01.031_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.coph.2008.06.015","article-title":"Targeting Hsp90: small-molecule inhibitors and their clinical development","author":"Taldone","year":"2008","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.bcp.2010.01.031_bib7","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.2174\/156802606777812004","article-title":"Inhibitors of the HSP90 molecular chaperone: attacking the master regulator in cancer","volume":"6","author":"McDonald","year":"2006","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.bcp.2010.01.031_bib8","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0065-230X(06)95009-X","article-title":"Inhibitors of the HSP90 molecular chaperone: current status","volume":"95","author":"Sharp","year":"2006","journal-title":"Adv Cancer Res"},{"key":"10.1016\/j.bcp.2010.01.031_bib9","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0092-8674(00)80314-1","article-title":"Identification and structural characterization of the ATP\/ADP-binding site in the Hsp90 molecular chaperone","volume":"90","author":"Prodromou","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2010.01.031_bib10","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0092-8674(00)80203-2","article-title":"Crystal structure of an Hsp90-geldanamycin complex: targeting of a protein chaperone by an antitumor agent","volume":"89","author":"Stebbins","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2010.01.031_bib11","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1021\/jm980403y","article-title":"Structural basis for inhibition of the Hsp90 molecular chaperone by the antitumor antibiotics radicicol and geldanamycin","volume":"42","author":"Roe","year":"1999","journal-title":"J Med Chem"},{"key":"10.1016\/j.bcp.2010.01.031_bib12","doi-asserted-by":"crossref","first-page":"3338","DOI":"10.1016\/j.bmcl.2005.05.046","article-title":"The identification, synthesis, protein crystal structure and in vitro biochemical evaluation of a new 3,4-diarylpyrazole class of Hsp90 inhibitors","volume":"15","author":"Cheung","year":"2005","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bcp.2010.01.031_bib13","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.chembiol.2006.09.015","article-title":"Inhibition of Hsp90 with synthetic macrolactones: synthesis and structural and biological evaluation of ring and conformational analogs of radicicol","volume":"13","author":"Proisy","year":"2006","journal-title":"Chem Biol"},{"key":"10.1016\/j.bcp.2010.01.031_bib14","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.2174\/156802609789895719","article-title":"Ansamycin Inhibitors of Hsp90: nature's prototype for anti-chaperone therapy","volume":"9","author":"Porter","year":"2009","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.bcp.2010.01.031_bib15","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1021\/jm701018h","article-title":"4,5-diarylisoxazole Hsp90 chaperone inhibitors: potential therapeutic agents for the treatment of cancer","volume":"51","author":"Brough","year":"2008","journal-title":"J Med Chem"},{"key":"10.1016\/j.bcp.2010.01.031_bib16","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1158\/0008-5472.CAN-07-5256","article-title":"NVP-AUY922: a novel heat shock protein 90 inhibitor active against xenograft tumor growth, angiogenesis, and metastasis","volume":"68","author":"Eccles","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2010.01.031_bib17","doi-asserted-by":"crossref","first-page":"10006","DOI":"10.1158\/0008-5472.CAN-05-2029","article-title":"Formation of 17-allylamino-demethoxygeldanamycin (17-AAG) hydroquinone by NAD(P)H:quinone oxidoreductase 1: role of 17-AAG hydroquinone in heat shock protein 90 inhibition","volume":"65","author":"Guo","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2010.01.031_bib18","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1158\/0008-5472.CAN-08-3131","article-title":"Acquired resistance to 17-allylamino-17-demethoxygeldanamycin (17-AAG, tanespimycin) in glioblastoma cells","volume":"69","author":"Gaspar","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2010.01.031_bib19","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/1471-2164-7-156","article-title":"Comparative genomics and evolution of the HSP90 family of genes across all kingdoms of organisms","volume":"7","author":"Chen","year":"2006","journal-title":"BMC Genomics"},{"key":"10.1016\/j.bcp.2010.01.031_bib20","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.ygeno.2005.08.012","article-title":"The HSP90 family of genes in the human genome: Insights into their divergence and evolution","volume":"86","author":"Chen","year":"2005","journal-title":"Genomics"},{"key":"10.1016\/j.bcp.2010.01.031_bib21","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.bbrc.2005.09.025","article-title":"A yeast-based assay reveals a functional defect of the Q488H polymorphism in human Hsp90alpha","volume":"337","author":"MacLean","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bcp.2010.01.031_bib22","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s10930-008-9160-1","article-title":"Single nucleotide polymorphism that accompanies a missense mutation (Gln488His) impedes the dimerization of Hsp90","volume":"28","author":"Kobayakawa","year":"2009","journal-title":"Protein J"},{"key":"10.1016\/j.bcp.2010.01.031_bib23","doi-asserted-by":"crossref","first-page":"13937","DOI":"10.1073\/pnas.93.24.13937","article-title":"Two eukaryote-specific regions of Hsp82 are dispensable for its viability and signal transduction functions in yeast","volume":"93","author":"Louvion","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bcp.2010.01.031_bib24","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0378-1119(02)01102-2","article-title":"Yeast is selectively hypersensitised to heat shock protein 90 (Hsp90)-targetting drugs with heterologous expression of the human Hsp90, a property that can be exploited in screens for new Hsp90 chaperone inhibitors","volume":"302","author":"Piper","year":"2003","journal-title":"Gene"},{"key":"10.1016\/j.bcp.2010.01.031_bib25","doi-asserted-by":"crossref","first-page":"4453","DOI":"10.1111\/j.1742-4658.2007.05974.x","article-title":"Expressed as the sole Hsp90 in yeast, the \u03b1 and \u03b2 isoforms of human Hsp90 differ in their capacities to activate certain client proteins, while only Hsp90\u03b2 sensitizes cells to the Hsp90 inhibitor radicicol","volume":"274","author":"Millson","year":"2007","journal-title":"FEBS J"},{"key":"10.1016\/j.bcp.2010.01.031_bib26","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.molbiopara.2008.12.011","article-title":"The complementation of yeast with human or Plasmodium falciparum Hsp90 confers differential inhibitor sensitivities","volume":"164","author":"Wider","year":"2009","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.bcp.2010.01.031_bib27","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1021\/cb9000316","article-title":"Structural basis of the radicicol resistance displayed by a fungal Hsp90","volume":"4","author":"Prodromou","year":"2009","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.bcp.2010.01.031_bib28","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1128\/MCB.19.1.402","article-title":"A trans-activation domain in yeast heat shock transcription factor is essential for cell cycle progression during stress","volume":"19","author":"Morano","year":"1999","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.bcp.2010.01.031_bib29","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1002\/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.0.CO;2-K","article-title":"Three new dominant drug resistance cassettes for gene disruption in Saccharomyces cerevisiae","volume":"15","author":"Goldstein","year":"1999","journal-title":"Yeast"},{"key":"10.1016\/j.bcp.2010.01.031_bib30","first-page":"207","article-title":"The pleitropic drug ABC transporters from Saccharomyces cerevisiae","volume":"3","author":"Rogers","year":"2001","journal-title":"J Mol Microbiol Biotechnol"},{"key":"10.1016\/j.bcp.2010.01.031_bib31","doi-asserted-by":"crossref","first-page":"4924","DOI":"10.1093\/nar\/23.23.4924","article-title":"A rapid and reliable DNA preparation method for screening a large number of yeast clones by polymerase chain reaction","volume":"23","author":"Ling","year":"1995","journal-title":"Nucl Acids Res"},{"key":"10.1016\/j.bcp.2010.01.031_bib32","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1093\/nar\/24.13.2519","article-title":"A new efficient gene disruption cassette for repeated use in budding yeast","volume":"24","author":"G\u00fcldener","year":"1996","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.bcp.2010.01.031_bib33","doi-asserted-by":"crossref","first-page":"4281","DOI":"10.1128\/MCB.6.12.4281","article-title":"Structure of the Saccharomyces cerevisiae HO gene and analysis of its upstream regulatory region","volume":"6","author":"Russell","year":"1986","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.bcp.2010.01.031_bib34","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1099\/00221287-145-12-3455","article-title":"The Hsp90 of Candida albicans can confer Hsp90 functions in Saccharomyces cerevisiae: a potential model for the processes that generate immunogenic fragments of this molecular chaperone in C. albicans infections","volume":"145","author":"Panaretou","year":"1999","journal-title":"Microbiology"},{"key":"10.1016\/j.bcp.2010.01.031_bib35","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.1093\/emboj\/19.16.4383","article-title":"The ATPase cycle of Hsp90 drives a molecular \u2018clamp\u2019 via transient dimerization of the N-terminal domains","volume":"19","author":"Prodromou","year":"2000","journal-title":"EMBO J"},{"key":"10.1016\/j.bcp.2010.01.031_bib36","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1742-4658.2008.06773.x","article-title":"A common conformationally coupled ATPase mechanism for yeast and human cytoplasmic HSP90s","volume":"276","author":"Vaughan","year":"2009","journal-title":"FEBS J"},{"key":"10.1016\/j.bcp.2010.01.031_bib37","doi-asserted-by":"crossref","first-page":"4829","DOI":"10.1093\/emboj\/17.16.4829","article-title":"ATP binding and hydrolysis are essential to the function of the Hsp90 molecular chaperone in vivo","volume":"17","author":"Panaretou","year":"1998","journal-title":"EMBO J"},{"key":"10.1016\/j.bcp.2010.01.031_bib38","series-title":"Methods in yeast genetics","author":"Adams","year":"1997"},{"key":"10.1016\/j.bcp.2010.01.031_bib39","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2174\/138945006776359403","article-title":"Fungal ATP-binding cassette (ABC) transporters in drug resistance & detoxification","volume":"7","author":"Sipos","year":"2006","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.bcp.2010.01.031_bib40","doi-asserted-by":"crossref","first-page":"3919","DOI":"10.1128\/MCB.9.9.3919","article-title":"Lindquist S. hsp82 is an essential protein that is required in higher concentrations for growth of cells at higher temperatures","volume":"9","author":"Borkovich","year":"1989","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.bcp.2010.01.031_bib41","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/nature04716","article-title":"Crystal structure of an Hsp90-nucleotide-p23\/Sba1 closed chaperone complex","volume":"440","author":"Ali","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2010.01.031_bib42","doi-asserted-by":"crossref","first-page":"3788","DOI":"10.1101\/gad.12.24.3788","article-title":"Regulation of the heat shock transcriptional response: cross talk between a family of heat shock factors, molecular chaperones, and negative regulators","volume":"12","author":"Morimoto","year":"1998","journal-title":"Genes Dev"},{"key":"10.1016\/j.bcp.2010.01.031_bib43","doi-asserted-by":"crossref","first-page":"4689","DOI":"10.1046\/j.1432-1033.2003.03866.x","article-title":"Sensitivity to Hsp90-targeting drugs can arise with mutation to the Hsp90 chaperone, cochaperones and plasma membrane ATP binding cassette transporters of yeast","volume":"270","author":"Piper","year":"2003","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.bcp.2010.01.031_bib44","doi-asserted-by":"crossref","first-page":"3446","DOI":"10.1128\/MCB.02246-07","article-title":"Picard D. p23\/Sba1p protects against Hsp90 inhibitors independently of its intrinsic chaperone activity","volume":"28","author":"Forafonov","year":"2008","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.bcp.2010.01.031_bib45","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1158\/0008-5472.CAN-07-3268","article-title":"Silencing of HSP90 cochaperone AHA1 expression decreases client protein activation and increases cellular sensitivity to the HSP90 inhibitor 17-allylamino-17-demethoxygeldanamycin","volume":"68","author":"Holmes","year":"2008","journal-title":"Cancer Res"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295210000699?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295210000699?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,13]],"date-time":"2018-12-13T12:26:21Z","timestamp":1544703981000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295210000699"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":45,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["S0006295210000699"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2010.01.031","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]}}}